| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| NE4-M52Ha | Mouse | Mouse Nectin-4 Protein, His Tag, low endotoxin |  |
|
|
| NE4-M5257 | Mouse | Mouse Nectin-4 Protein, Fc Tag (MALS verified) |  |
|
|
| NE4-HF2H3 | Human | FITC-Labeled Human Nectin-4 Protein, His Tag |  |
|
|
| NE4-H5255 | Human | Human Nectin-4 Protein, Fc Tag |  |
|
|
| NE4-M52H3 | Mouse | Mouse Nectin-4 Protein, His Tag |  |
|
|
| NE4-C52H4 | Cynomolgus | Cynomolgus Nectin-4 Protein, His Tag |  |
|
|
| NE4-H82E7 | Human | Biotinylated Human Nectin-4 Protein, His,Avitag™ |  |
|
|
| NE4-H52H3 | Human | Human Nectin-4 Protein, His Tag |  |
|
|
Loaded Mouse Nectin-4, Fc Tag (Cat. No. NE4-M5257) on Protein A Biosensor, can bind Human Nectin-1, His Tag (Cat. No. PV1-H5223) with an affinity constant of 278 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested)
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Enfortumab vedotin | AGS-M6; AGS-22ME; ASG-22CE; ASG-22ME; AGS-22M6E; ASG-22M6E; AGS-22C3; DLE8519RWM | Approved | Agensys, Seattle Genetics | Padcev | United States | Urologic Neoplasms; Urinary Bladder Neoplasms | s:19:"Astellas Pharma Inc"; | 2019-12-18 | Solid tumours; Kidney Neoplasms; Carcinoma; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Urethral Neoplasms; Ureteral Neoplasms; Urologic Neoplasms | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Nectin4/FAP-targeted CAR-T cell therapy (The Sixth Affiliated Hospital of Wenzhou Medical University) | Phase 1 Clinical | Wenzhou Medical University | Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z